Home/Filings/4/0001209191-22-046962
4//SEC Filing

Kashmolah Ghazi 4

Accession 0001209191-22-046962

CIK 0001652724other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 9:40 PM ET

Size

6.6 KB

Accession

0001209191-22-046962

Insider Transaction Report

Form 4
Period: 2022-08-17
Kashmolah Ghazi
Ex. VP &Chief Quality Officer
Transactions
  • Sale

    Common Stock

    2022-08-17$2.83/sh19,074$53,979180,757 total
  • Sale

    Common Stock

    2022-08-18$2.25/sh3,500$7,875177,257 total
Footnotes (2)
  • [F1]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on September 30, 2021 for 197,240 shares.
  • [F2]Includes 2,591 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on February 20, 2022.

Issuer

Lucira Health, Inc.

CIK 0001652724

Entity typeother

Related Parties

1
  • filerCIK 0001877741

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 9:40 PM ET
Size
6.6 KB